Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Delaporte

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Investigative Dermatology|August 24, 2007
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control studyPascal Joly, Cloe Benoit-Corven, Sophie Baricault, et al.
Intensive Care Medicine|March 18, 2017
Impact of tapered-cuff tracheal tube on microaspiration of gastric contents in intubated critically ill patients: a multicenter cluster-randomized cross-over controlled trialEmmanuelle Jaillette, Christophe Girault, Guillaume Brunin, et al.
Journal of the American Academy of Dermatology|March 12, 2016
Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseasesColine Faivre, Axel Patrice Villani, François Aubin, et al.
Archives of Dermatology|September 19, 2007
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 casesFlorent Grange, Marie Beylot-Barry, Phillipe Courville, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.
The Journal of Investigative Dermatology|January 30, 2009
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized studyPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Science Translational Medicine|March 8, 2013
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell responseNatacha Colliou, Damien Picard, Frédérique Caillot, et al.
Archives of Dermatology|July 18, 2012
Prognostic factors of paraneoplastic pemphigusSandy Leger, Damien Picard, Saskia Ingen-Housz-Oro, et al.
The British Journal of Dermatology|March 10, 2026
Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trialOlivier Dereure, Philippe Bernard, Olivier Chosidow, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Investigative Dermatology|August 24, 2007
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control studyPascal Joly, Cloe Benoit-Corven, Sophie Baricault, et al.
Intensive Care Medicine|March 18, 2017
Impact of tapered-cuff tracheal tube on microaspiration of gastric contents in intubated critically ill patients: a multicenter cluster-randomized cross-over controlled trialEmmanuelle Jaillette, Christophe Girault, Guillaume Brunin, et al.
Journal of the American Academy of Dermatology|March 12, 2016
Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseasesColine Faivre, Axel Patrice Villani, François Aubin, et al.
Archives of Dermatology|September 19, 2007
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 casesFlorent Grange, Marie Beylot-Barry, Phillipe Courville, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.
The Journal of Investigative Dermatology|January 30, 2009
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized studyPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Science Translational Medicine|March 8, 2013
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell responseNatacha Colliou, Damien Picard, Frédérique Caillot, et al.
Archives of Dermatology|July 18, 2012
Prognostic factors of paraneoplastic pemphigusSandy Leger, Damien Picard, Saskia Ingen-Housz-Oro, et al.
The British Journal of Dermatology|March 10, 2026
Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trialOlivier Dereure, Philippe Bernard, Olivier Chosidow, et al.
Pageof 5